We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
(-2.6%)
Cap. Flow
-$4.15B
Cap. Flow
% of AUM
-9.34%
Top 10 Holdings %
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$309M |
| 2 |
ExxonMobil
XOM
|
+$302M |
| 3 |
Amazon
AMZN
|
+$291M |
| 4 |
Citigroup
C
|
+$253M |
| 5 |
Shopify
SHOP
|
+$238M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$383M |
| 2 |
Johnson & Johnson
JNJ
|
+$312M |
| 3 |
JPMorgan Chase
JPM
|
+$285M |
| 4 |
AT&T
T
|
+$191M |
| 5 |
Dollar General
DG
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.63% |
| 2 | Financials | 15.61% |
| 3 | Technology | 14.28% |
| 4 | Consumer Discretionary | 13.21% |
| 5 | Industrials | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACQR
426
DELISTED
Independence Holdings Corp. Class A Ordinary Share
ACQR
| $21.2M | 0.05% |
2,100,302
| – | – |
|
427
BHP
BHP
$213B
| $21M | 0.05% |
339,005
+190,269
| +128% | +$10.7M |
|
428
Envoy Medical
COCH
$51M
| $21M | 0.05% |
2,080,871
| – | – |
|
|
CCV
429
DELISTED
Churchill Capital Corp V
CCV
| $20.9M | 0.05% |
2,106,739
| – | – |
|
|
JWSM
430
DELISTED
Jaws Mustang Acquisition Corp.
JWSM
| $20.8M | 0.05% |
2,059,417
-3,010,998
| -59% | -$30.2M |
|
431
Illinois Tool Works
ITW
$81.4B
| $20.8M | 0.05% |
+94,391
| New | +$20.1M |
|
|
GAP
432
The Gap Inc
GAP
$6.84B
| $20.6M | 0.05% |
+1,827,752
| New | +$21.9M |
|
433
ICL Group
ICL
$6.81B
| $20.5M | 0.05% |
2,798,935
+620,557
| +28% | +$5.14M |
|
434
Altimmune
ALT
$539M
| $20.4M | 0.05% |
1,239,794
+140,880
| +13% | +$1.58M |
|
435
Freeport-McMoran
FCX
$90B
| $20.3M | 0.05% |
535,471
+420,990
| +368% | +$14.7M |
|
|
LTHM
436
DELISTED
Livent Corporation
LTHM
| $20.3M | 0.05% |
1,022,446
+812,979
| +388% | +$22.2M |
|
|
DGNU
437
DELISTED
Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares
DGNU
| $20.2M | 0.05% |
2,055,283
| – | – |
|
|
AGAC
438
DELISTED
African Gold Acquisition Corp
AGAC
| $20.2M | 0.05% |
2,009,992
| – | – |
|
439
Linde
LIN
$237B
| $20.2M | 0.05% |
+61,812
| New | +$19.4M |
|
|
PDOT
440
DELISTED
Peridot Acquisition Corp. II
PDOT
| $20.1M | 0.05% |
1,985,007
| – | – |
|
441
Bentley Systems
BSY
$9.54B
| $20M | 0.04% |
540,299
+240,673
| +80% | +$8.72M |
|
|
ANSS
442
DELISTED
Ansys
ANSS
| $19.9M | 0.04% |
82,501
+49,686
| +151% | +$11.6M |
|
|
PYCR
443
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $19.9M | 0.04% |
814,415
+591,473
| +265% | +$16.4M |
|
444
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
| $19.8M | 0.04% |
+198,551
| New | +$20M |
|
445
Fastenal
FAST
$54B
| $19.7M | 0.04% |
833,076
-2,494,210
| -75% | -$61M |
|
|
TCVA
446
DELISTED
TCV Acquisition Corp. Class A Ordinary Shares
TCVA
| $19.7M | 0.04% |
1,949,722
| – | – |
|
447
CALL
Alphabet (Google) Class A
GOOGL
$3.91T
| $19.6M | 0.04% |
222,400
+21,700
| +11% | +$2.06M |
|
448
Lincoln National
LNC
$7.91B
| $19.6M | 0.04% |
638,404
+394,582
| +162% | +$15.7M |
|
449
Microchip Technology
MCHP
$42.8B
| $19.6M | 0.04% |
+279,060
| New | +$19.2M |
|
450
Tronox
TROX
$995M
| $19.5M | 0.04% |
1,425,257
+623,778
| +78% | +$8.3M |
|
Similar funds
Marshall Wace's Q4 2022 Portfolio in Review
As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.
- Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
- Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
- Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
- Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
- Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
- Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.
Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.